venetoclax,quizartinib
daiichi sankyo,Abbvie,roche
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'quantum-first', 'daiichisankyous', 'daiichi']
news: our phase 3 quantum-first data in patients with newly diagnosed aml were featured at the #eha2022 press briefing and will be presented later today at the presidential symposium at #eha2022 (abstract s100). learn more: 
Daiichi Sankyo US’s channel featuring our biopharmaceutical news, passion for innovation & compassion for patients.  See our guidelines: https://t.co/4iEAbpw1Wx